ACM impedes the heart from pumping blood to the rest of the body, and is a leading cause of sudden cardiac death in young ...
Aradigm Health, a new benefits platform aimed at easing the financial sting of coverage for cell and gene therapies, has launched out of stealth. The company is making its debut backed by a $20 ...
Cincinnati Children's is nearly ready to move into its new Applied Gene and Cell Therapy Center in Sharonville, a $60 million project. DAVID STEPHEN FOR ACBJ To ...
For years, cell and gene therapies were mainly associated with rare and orphan diseases, those that impact small patient groups and lack effective treatment options. However, recent developments in ...
Complexities like these make it challenging to develop broadly applicable gene therapies for these disorders. Researchers at The University of Texas at Austin now have developed an improved method of ...
In a new study published in Nature Communications titled, “The reference genome of the human diploid cell line RPE-1,” researchers from University of Rome La Sapienza have produced the first reference ...
The MarketWatch News Department was not involved in the creation of this content. SAN DIEGO, Sept. 15, 2025 /PRNewswire/ -- Abzena, the leading end-to-end integrated CDMO for complex biologics and ...
Crispr gene-editing technology has demonstrated its revolutionary potential in recent years: It has been used to treat rare diseases, to adapt crops to withstand the extremes of climate change, or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results